Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Uterine Neoplasms × niraparib × Clear all

Phase

Phase EARLY_PHASE1 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioma 2 Uterine Neoplasms 1 Sarcoma 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Glioblastoma 1 Endometrial Neoplasms 1 Cystadenocarcinoma, Serous 1 Breast Neoplasms 1

Interventions

pembrolizumab 1 niraparib 1 Hysterectomy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05289648 2024-12-19

NIREC

Sir Mortimer B. Davis - Jewish General Hospital

Phase EARLY_PHASE1 Withdrawn

Uterine Neoplasms, Endometrial Neoplasms, Cystadenocarcinoma, Serous

Data powered by HemOnc (CC BY 4.0) Colophon ⚡